Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 140   

Articles published

VRX 237.53
price chart
Billionaire John Paulson Doubles Down on Valeant Pharmaceuticals Intl Inc.
Billionaire hedge fund manager John Paulson has more than tripled the size of his stake in Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), which could suggest the biotech giant has a lot more upside ahead of it. Valeant has become a favourite ...
Valeant Pharmaceuticals International Inc CEO primed for more deals  Financial Post
Valeant Pharmaceuticals Announces 2015 Annual Meeting Results  PR Newswire (press release)
Valeant Pharmaceuticals International Inc wooing Egyptian drugmaker, wants to ...
In March, Valeant beat Endo International Plc in a bidding war to acquire Salix Pharmaceuticals Inc. for $11.1 billion.
Valeant in talks to buy Egyptian drugmaker Amoun Pharma: Bloomberg  Yahoo News
Valeant Said to Be in Talks to Acquire Egyptian Drugmaker Amoun  Bloomberg
Valeant Pharmaceuticals International Inc. is becoming the 800-pound gorilla ...
Scott Eells/Bloomberg Valeant Pharmaceuticals International Inc. chief executive Michael Pearson, has stated his company's goal is to become one of the top five largest drugmakers in the world by 2016, which means reaching a market value of at least ...
Valeant gains clout with support from big-betting hedge funds  Montreal Gazette
At midday: TSX sags on global jitters  The Globe and Mail
Is Valeant Pharmaceuticals Intl Inc. Another Berkshire Hathaway?
While the title might seem totally bombastic, Bill Ackman, the hedge fund manager of Pershing Square Capital, believes that Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could actually be an early-stage Berkshire Hathaway. The reason Ackman ...
Robert Chaionn Insider Deal for 90938 Shares of Valeant Pharmaceuticals Intl ...  OctaFinance.com
Insider Selling: Facebook Inc (FB), Valeant Pharmaceuticals Intl Inc (VRX ...  Bidness ETC
Valeant Pharmaceuticals International Inc's bid for Salix Pharmaceuticals ...
Canadian Press//Ryan RemiorzValeant Pharmaceuticals International Inc's chief executive Mike Pearson agreed to buy bowel drug maker Salix Pharmaceuticals Ltd in late February for about US$10 billion, or US$158 all cash offer per share.
Valeant Comments On Endo Offer To Acquire Salix  Canada NewsWire (press release)
Endo offers about $11B for Salix, trumping Valeant  STLtoday.com
Is Valeant Pharmaceuticals Intl Inc a $250 Stock?
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has a long history of growing through acquisitions. In fact as I write this article it is rumoured to have secured financing to purchase Salix Pharmaceuticals.
Valuation Perspetives: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)  Stock Markets Daily
Valeant Pharmaceuticals International Inc. victorious in battle for Salix ...
Valeant Pharmaceuticals International Inc. (TSX:VRX) says its US$11.1-billion friendly takeover bid for Salix Pharmaceuticals, Ltd.
Valeant Pharmaceuticals Intl Inc. Acquired Salix Pharmaceuticals Ltd.:Now What?  The Motley Fool Canada
Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix ...  Stockhouse
Valeant Pharmaceuticals International Inc faces high execution risk
The market clearly likes Valeant Pharmaceuticals International Inc.'s aggressive acquisition strategy, as the stock continues to consistently move higher.
Waiting for Reversal: Dendreon Corporation (OTCMKTS:DNDNQ)  MicroCap Daily
Deal-Making Valeant Pharmaceuticals Intl Inc. Shows No Signs of Slowing Down
The Toronto Stock Exchange is dominated by energy and financial stocks. But over the past few months, one of the best-performing sectors on the TSX has been healthcare, led by Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), an acquisitive drug ...
Valeant Pharmaceuticals Intl's Buy Rating Reaffirmed at Cantor ...  sleekmoney
Inorganic Growth Becoming Norm For US Pharma As Endo International Loses ...  InvestCorrectly
Should You Buy Valeant Pharmaceuticals Intl Inc. on the Salix Pharmaceuticals ...
It didn't take long for Valeant Pharmaceuticals Intl. Inc. (TSX:VRX)(NYSE:VRX) to start acquiring again after the recent failure at acquiring Allergan, Inc. Despite the fact the CEO talked about taking a few quarters to start paying down debt and ...
Valeant To Acquire Salix Pharmaceuticals For $158.00 Per Share In Cash  Canada NewsWire (press release)
Valeant Pharmaceuticals to buy Salix for $10.1bn  Economic Times